Whole Body PET-MRI in Paediatric and Adolescent Lymphoma
NCT02935348 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2016-10-17
Summary
Children and adolescents with Hodgkin lymphoma currently undergo multiple investigations including a separate PET and MRI scans during their treatment.
Investigators want to investigate if a combined PET-MRI scan could give the same information.
Children who join our study will have an extra scan twice during their treatment
Conditions
Interventions
- RADIATION
-
Whole Body MRI
Routine whole body clinical MRI will be performed according to current clinical standard of care. Axial and coronal imaging from the maxilla to proximal femurs will be performed using a combination of T1 and T2 weighted sequences, with and without gadolinium administration.
Sponsors & Collaborators
-
University College, London
lead OTHER
Principal Investigators
-
Paul Humphries · UCL
Eligibility
- Max Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-02-28
- Primary Completion
- 2017-05-31
- Completion
- 2017-05-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Real-life Efficacy and Toxicity of Brentuximab-Vedotin Associated With Bendamustine in Patients With Relapsed or Refractory Hodgkin Lymphoma (HL-R2-B2)
NCT07145125 ·Status: COMPLETED
-
Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma Patients
NCT01228461 ·Status: COMPLETED
-
Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation
NCT01820117 ·Status: COMPLETED
-
PD-L1 PET-imaging During CAR T-cell Therapy
NCT05404048 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD
NCT02298283 ·Status: COMPLETED ·Phase: PHASE2
-
Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia
NCT00324779 ·Status: COMPLETED ·Phase: PHASE2
-
Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients
NCT01516580 ·Status: COMPLETED ·Phase: PHASE3
-
Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma
NCT05253495 ·Status: RECRUITING ·Phase: PHASE2
-
Brown Fat Activity and White Fat Accumulation
NCT01517581 ·Status: COMPLETED
-
Azacytidine Plus Chidamide in the Treatment of Relapsed and Refractory Angioimmunoblastic T-cell Lymphoma
NCT05179213 ·Status: UNKNOWN ·Phase: PHASE2
-
Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients
NCT02108444 ·Status: COMPLETED
-
R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma
NCT00809341 ·Status: TERMINATED ·Phase: PHASE2
-
Interim PET/CT Guided Cycle Numbers of R-CHOP in DLBCL
NCT01804127 ·Status: UNKNOWN ·Phase: PHASE2
-
A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma (HL).
NCT00301314 ·Status: COMPLETED
-
Study Of Intratumoral G100 In Cutaneous T Cell Lymphoma
NCT03742804 ·Status: WITHDRAWN ·Phase: PHASE2
-
Tailored Therapy for Hodgkin Lymphoma Using Early Interim Therapy PET for Therapy Decision.
NCT00392314 ·Status: COMPLETED ·Phase: PHASE2
-
(TAA)-Specific Cytotoxic T-Lymphocytes to Pediatric Patients With Lymphomas (pediTACTAL).
NCT05134740 ·Status: WITHDRAWN ·Phase: PHASE1
-
Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia
NCT02618109 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of the Relationship Between Anti-PD-1 Exposure and Tumour VOLUME in Patients Treated for Classical HODgkin's Lymphoma.
NCT04621604 ·Status: TERMINATED ·Phase: NA
-
Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients
NCT02098512 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
IIT CTI Bendamustine, Rituximab, Pixantrone in Relapsed/Refractory B Cell Non-Hodgkin's Lymphoma
NCT01491841 ·Status: COMPLETED ·Phase: PHASE1
-
A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With LBL
NCT03971318 ·Status: UNKNOWN
-
Proton Radiation for Lymphoma Involving Mediastinum
NCT01751412 ·Status: TERMINATED ·Phase: NA
-
Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation
NCT01516567 ·Status: COMPLETED ·Phase: PHASE2
-
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
NCT06098430 ·Status: RECRUITING